Active Ingredient: OLOPATADINE HYDROCHLORIDE
Proprietary Name: OLOPATADINE HYDROCHLORIDE
Dosage Form; Route of Administration: SOLUTION/DROPS; OPHTHALMIC
Strength: EQ 0.2% BASE
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A204723
Product Number: 001
Approval Date: Dec 5, 2017
Applicant Holder Full Name: SAPTALIS PHARMACEUTICALS LLC
Marketing Status:
Discontinued
Patent and Exclusivity Information